6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
Just now	Chevron Introduces Next-gen Techron in U.S. Chevron and Texaco Gasolines
Just now	GreenPower Unveils Innovative Heating Solution for Type A Nano BEAST All-Electric, Purpose-Built, Zero-Emission School Bus
8m ago	Yapi ve Kredi Bankasi : Successful issuance of 500 million US$ perpetual Additional Tier 1 Capital Transaction
13m ago	Crown Castle Names Kris Hinson as Chief Commercial Officer and Mark Lennon as Chief Information Officer
18m ago	Hovnanian Enterprises Reports Fiscal 2026 Second Quarter Results

About

20.85USD+1.05 +5.30%

Closed • Updated at 13:34 GMT+00:00

Market Cap$10.41B

Volume8.00M

Beta1.37

RSI42.51

Gross Margin43.76%

Health TechnologyBiotechnology

Elanco Animal Health Incorporated — investor relations, events, news, and company updates on 6ix.

Latest News

Elanco Launches Befrena™ (tirnovetmab), New Anti-IL-31 Monoclonal Antibody, a Breakthrough Addition to the $1.3 Billion U.S. Canine Dermatology Market

Elanco Animal Health Reports First Quarter 2026 Results

/C O R R E C T I O N -- Elanco Animal Health/

Elanco's Negasunt™ Powder (Coumaphos, Propoxur, Sulfanilamide Topical Powder) and Tanidil™ (Coumaphos, Propoxur) Receive Emergency Authorization for Use Against New World Screwworm in Livestock

Elanco Confirms Date and Conference Call for First Quarter 2026 Financial Results Announcement

Community Chat

Ask AI